Aetna Medical Policy Updates – February 2023

Click here to view the Aetna Medical Policy Updates »

February 2023 Aetna Medical Policy Updates:

• Abdominoplasty, Suction Lipectomy, and Ventral Hernia Repair
• Adoptive Immunotherapy and Cellular Therapy
• Allergy and Hypersensitivity
• Antineoplaston Therapy and Sodium Phenylbutyrate
• Back Pain – Invasive Procedures
• Belantamab Mafodotin-blmf (Blenrep)
• Bone Mass Measurements
• Bortezomib (Velcade)
• Botulinum Toxin
• Botulinum Toxin [Medicare]
• Breast Biopsy Procedures
• Brexanolone (Zulresso)
• Brexucabtagene Autoleucel (Tecartus)
• Calcitriol, Etelcalcetide, and Paricalcitol Injections
• Cardiac Catheter Ablation and Radioablation
• Cardiovascular Disease Risk Tests
• Carfilzomib (Kyprolis)
• Clotting Factors
• Cochlear Implants and Auditory Brainstem Implants
• Cosmetic Surgery
• Coumadin (Warfarin) to Heparin Conversion Before and After Elective Surgery
• Cryoablation
• Daratumumab
• Dental Services and Oral and Maxillofacial Surgery: Coverage Under Medical Plans
• Diabetes Tests, Programs and Supplies
• Elotuzumab (Empliciti)
• Esketamine (Spravato)
• Evoked Potential Studies
• Fetal Echocardiography and Magnetocardiography
• Gender Affirming Surgery
• General Anesthesia and Monitored Anesthesia Care for Oral and Maxillofacial Surgery and Dental Services
• Hematopoietic Colony-Stimulating Factors (CSFs)
• Hematopoietic Colony-Stimulating Factors (CSFs) [Medicare]
• Hyperbaric Oxygen Therapy (HBOT)
• Idecabtagene Vicleucel (Abecma)
• Infertility
• Inflammatory Bowel Disease: Serologic Markers and Pharmacogenomic and Metabolic Assessment of Thiopurine Therapy
• Infusion Pumps
• Intervertebral Disc Prostheses
• Intravenous Iron Therapy
• Isatuximab-irfc (Sarclisa)
• Lisocabtagene Maraleucel (Breyanzi)
• Liver Transplantation
• Lumasiran (Oxlumo)
• Lyme Disease and other Tick-Borne Diseases
• Magnetic Resonance Imaging (MRI) of the Breast
• Mammography
• Obesity Surgery
• Occupational Therapy
• Orthognathic Surgery
• Pembrolizumab (Keytruda)
• Pharmacogenetic and Pharmacodynamic Testing
• Physical Therapy
• Romosozumab-aqqg (Evenity)
• Romosozumab-aqqg (Evenity) [Medicare]
• Sinus Surgeries
• Skin and Soft Tissue Substitutes
• Teriparatide
• Tumor Scintigraphy
• Vagus Nerve Stimulation
• Zoledronic Acid

Click here to view the Aetna Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.